Skip to main content

Advertisement

Log in

Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Research on the prognostic value of lymph node ratio (LNR) in gastric cancer (GC) remains limited and controversial results were obtained. In this study, we aimed to evaluate whether LNR was an independent prognostic factor for gastric carcinoma. A retrospective review of a database of gastric cancer patients was performed to determine the effect of the LNR on the overall survival (OS) and the disease-free survival (DFS). Of the total 135 patients with gastric cancer who underwent resection between March 2012 and December 2013, 44 patients with non metastatic gastric cancer were eligible for analysis. Survival curves were estimated using the Kaplan-Meier method. Cox regression analyses, after adjustments for potential confounders, were used to evaluate the relationship between the LNR and survival. According to the cutoff point 0.37 (37 %), the one-year OS rate for LNR ≤ 37 % was significantly better than that for LNR > 37 % (91.3 % and 61.9 %, respectively, P = 0.02). The one-year DFS for LNR ≤ 37 % was significantly better than that for LNR > 37 % (91.3 % and 66.7 %, respectively, P = 0.027). In stratified and multivariate analyses adjusted for age, gender, histology and tumor status, a higher LNR was associated with high pN stage and so associated with worse OS and DFS. Thus, the LNR 37 % as a cutoff point was found not to be an independent factor for predicting the one-year OS or DFS in patients with non-metastatic GC. The LNR is a prognostic factor in GC. However, no single cut-off value was determined as an independent prognostic factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Hartgrink HH, Jansen EP, van Grieken NC, Van de Velde CJ (2009) Gastric cancer. Lancet 374:477–490

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wang XN, Liang H (2010) Some problems in the surgical treatment of gastric cancer. Chin J Cancer 29:369–373

    Article  PubMed  Google Scholar 

  4. Lee SY, Hwang I, Park YS, Gardner J, Ro JY (2010) Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes? Int J Oncol 36(6):1461–1467

    PubMed  Google Scholar 

  5. Fleming ID, Cooper JS, Henson DE, et al. (1997) American joint committee on cancer, cancer staging Manuel. Lippincott-Raven, Philadelphia, pp 71-76

  6. Sobin LH, Wittekind CH (1997) International union against cancer (UICC): TMN classification of malignant tumors, 5th edn. John Wiley & Sons, New York

    Google Scholar 

  7. Lemmens VE, Dassen A (2011) E, van der wurff a a, coebergh JW and bosscha K: lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol 37:488–496

    Article  CAS  PubMed  Google Scholar 

  8. Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D’Ugo D (2008) Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 34:519–524

    Article  CAS  PubMed  Google Scholar 

  9. Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, et al. (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34

    Article  PubMed  Google Scholar 

  10. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784

    Article  PubMed  Google Scholar 

  11. Weir L, Speers C, D’yachkova Y, Olivotto IA (2002) Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20:1793–1799

    Article  CAS  PubMed  Google Scholar 

  12. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298

    Article  PubMed  Google Scholar 

  13. Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240

    PubMed  Google Scholar 

  14. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL (2003) Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21:1029–1034

    Article  PubMed  Google Scholar 

  15. Attaallah W, Gunal O, Manukyan M (2013) Ozden G and yegen C: prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Ann Coloproctol 29(3):100–105

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wu HL, Tian Q, Peng CW, Liu SP, Li Y (2011) Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution. Asian Pac J Cancer Prev 12:3341–3345

    PubMed  Google Scholar 

  17. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077–1085

    Article  PubMed  Google Scholar 

  18. Marchet A, Mocellin S, Ambrosi A, et al. (2007) The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy. Ann Surg 245:543–552

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liu C, Lu P, Lu Y, Xu H, Wang S, Chen J (2007) Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer 7:200

    Article  PubMed  PubMed Central  Google Scholar 

  20. Celen O, Yildirim E, Berberoglu U (2007) Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol 96:95–101

    Article  PubMed  Google Scholar 

  21. Zeng WJ, Hu WQ, Wang LW, et al. (2013) Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: a retrospective study of 138 cases. Oncology Letters 6(6):1693–1700

    PubMed  PubMed Central  Google Scholar 

  22. Nelen SD, van Steenbergen LN, Dassen AE, van der Wurff AA, Lemmens VE, Bosscha K (2013) The lymph node ratio as a prognostic factor for gastric cancer. Acta Oncol 52(8):1751–1759

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wafi Attaallah.

Ethics declarations

Conflict of Interest

We hereby declare explicitly that we have no relationship with any third party of conflict of interest or a fund that support our study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Attaallah, W., Uprak, K., Gunal, O. et al. Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer. Indian J Surg Oncol 7, 67–72 (2016). https://doi.org/10.1007/s13193-016-0490-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0490-8

Keywords

Navigation